These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3709650

  • 21. Transfer of enprofylline into breast milk.
    Laursen LC, Borgå O, Ljungholm K, Weeke B.
    Ther Drug Monit; 1988; 10(2):150-2. PubMed ID: 3381231
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Tolerance and some circulatory effects of intravenous and oral enprofylline in healthy volunteers.
    Lunell E, Andersson KE, Persson CG.
    Acta Pharmacol Toxicol (Copenh); 1983 Sep; 53(3):205-11. PubMed ID: 6637510
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of probenecid on the elimination and protein binding of ceftriaxone.
    Stoeckel K, Trueb V, Dubach UC, McNamara PJ.
    Eur J Clin Pharmacol; 1988 Sep; 34(2):151-6. PubMed ID: 3383987
    [Abstract] [Full Text] [Related]

  • 28. The possible mechanism of interaction between xanthines and quinolone.
    Hasegawa T, Nadai M, Kuzuya T, Muraoka I, Apichartpichean R, Takagi K, Miyamoto K.
    J Pharm Pharmacol; 1990 Nov; 42(11):767-72. PubMed ID: 1982300
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion.
    Laursen LC, Johannesson N, Søndergaard I, Weeke B.
    Br J Clin Pharmacol; 1984 Oct; 18(4):591-5. PubMed ID: 6487499
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of enprofylline administered intravenously and as a sustained-release tablet at steady state in children with asthma.
    Watson WT, Simons KJ, Simons FE.
    J Pediatr; 1988 Apr; 112(4):658-62. PubMed ID: 3351694
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose.
    Lunell E, Borgå O, Larsson R.
    Eur J Clin Pharmacol; 1984 Apr; 26(1):87-93. PubMed ID: 6714295
    [Abstract] [Full Text] [Related]

  • 33. Intravenous enprofylline in asthma patients.
    Lunell E, Andersson KE, Persson CG, Svedmyr N.
    Eur J Respir Dis; 1984 Jan; 65(1):28-34. PubMed ID: 6705855
    [Abstract] [Full Text] [Related]

  • 34. Renal handling of captopril: effect of probenecid.
    Sinhvi SM, Duchin KL, Willard DA, McKinstry DN, Migdalof BH.
    Clin Pharmacol Ther; 1982 Aug; 32(2):182-9. PubMed ID: 7047044
    [Abstract] [Full Text] [Related]

  • 35. Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats.
    Kuh HJ, Shim CK.
    Arch Pharm Res; 1994 Apr; 17(2):124-30. PubMed ID: 10319144
    [Abstract] [Full Text] [Related]

  • 36. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M, Roberts C, Branch RA.
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [Abstract] [Full Text] [Related]

  • 37. Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid.
    Rengelshausen J, Göggelmann C, Burhenne J, Riedel KD, Mikus G, Walter-Sack I, Haefeli WE.
    Int J Clin Pharmacol Ther; 2007 Aug; 45(8):431-7. PubMed ID: 17725176
    [Abstract] [Full Text] [Related]

  • 38. Effect of theophylline and enprofylline on bronchial hyperresponsiveness.
    Koëter GH, Kraan J, Boorsma M, Jonkman JH, van der Mark TW.
    Thorax; 1989 Dec; 44(12):1022-6. PubMed ID: 2694418
    [Abstract] [Full Text] [Related]

  • 39. Decreased renal clearance of xanthine and hypoxanthine in a patient with renal hypouricemia: a new defect in renal handling of purines.
    Kawachi M, Kono N, Kiyokawa H, Mineo I, Nakajima H, Shimizu T, Yorifuji S, Kuwajima M, Tarui S.
    Nephron; 1992 Dec; 61(4):428-31. PubMed ID: 1501740
    [Abstract] [Full Text] [Related]

  • 40. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U, Sörgel F, Reiter A, Sigl G, Naber KG, Schunack W.
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.